Xeris Biopharma Holdings Insider Sold Shares Worth $383,176, According to a Recent SEC Filing
Steven Pieper, CFO, on July 06, 2026, sold 45,000 shares in Xeris Biopharma Holdings (XERS) for $383,176. Following the Form 4 filing with the SEC, Pieper has control over a total of 1,366,053 common shares of the company, with 1,366,053 shares held directly. SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.